The (Cold) Drugs Don’t Work
The FDA continues to permit the inclusion of an ineffective ingredient in hundreds of cough and cold products.
How the “Don’t take this medication with grapefruit juice” warning originated
How a chance discovery by one scientist improved the safety of consumers worldwide.
The Polypill Comes of Age
The polypill is effective for secondary prevention of cardiovascular disease. By combining drugs in a single pill, it improves convenience and compliance.
PreP for HIV/AIDS
Two pills and an injection are FDA-approved to prevent HIV infection. Not enough patients and providers know about them.
Zinc for the prevention or treatment of respiratory tract infections: A new systematic review
A new systematic review examines the evidence for zinc to prevent or treat respiratory tract infections.
What are the risks of touching fentanyl?
There is the widespread belief that simply touching fentanyl can be fatal. This assumption isn't supported by science or evidence.
Melatonin poisonings in children are increasing
Melatonin use is increasing, and accelerated during the pandemic. Overdoses are also increasing in children, and in rare cases are linked to serious harms.
Good faith doctoring or greedy drug dealing? SCOTUS hears opioid prescribing cases
Physicians running opioid "pill mills" were convicted of violating the Controlled Substances Act and given substantial prison sentences. The U.S. Supreme Court will soon decide whether they were entitled to a "good faith" defense at trial.
Pfizer’s new COVID-19 protease inhibitor drug is not just “repackaged ivermectin”
Pfizer recently announced that its new protease inhibitor-based drug was 89% effective in preventing hospitalization due to COVID-19 and it is seeking an emergency use authorization for it from the FDA. Antivaxxers claim that ivermectin targets the same protease and is being "suppressed" to protect Pfizer's profits from the new drug. What's the real story? Hint: Antivaxxers took a grain of truth...